{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:13:14Z","timestamp":1761156794062,"version":"3.44.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bulcan.2019.09.010","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T09:23:20Z","timestamp":1576747400000},"page":"84-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Radioth\u00e9rapie et immunosuppression\u00a0: synth\u00e8se de la litt\u00e9rature"],"prefix":"10.1016","volume":"107","author":[{"given":"Claire","family":"Bosacki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Vallard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Jmour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed","family":"Ben Mrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaimaa","family":"Lahmamssi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Bousarsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Vial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Daguenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2019.09.010_bib0335","first-page":"339","article-title":"Concomitant methotrexate and radiotherapy in advanced head and neck cancer\u00a0: 15-year follow-up of a randomized clinical trial","volume":"13","author":"Gupta","year":"2001","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0340","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0936-6555(05)80658-2","article-title":"An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery","volume":"8","author":"Fernando","year":"1996","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0345","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit \u2013 METHOTREXATE BIODIM 5mg\/2mL, solution injectable \u2013 Base de donn\u00e9es publique des m\u00e9dicaments n.d. http:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=67961853&typedoc=R [consult\u00e9 le 1\u00a0jul 2019]."},{"key":"10.1016\/j.bulcan.2019.09.010_bib0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2005.12.013","article-title":"Influence of connective tissue diseases on the expression of radiation side effects: a systematic review","volume":"78","author":"H\u00f6lscher","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0355","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clon.2015.05.001","article-title":"Acute and late bowel toxicity in radiotherapy patients with inflammatory bowel disease: a systematic review","volume":"27","author":"Tromp","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0360","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/bju.14018","article-title":"Prostate cancer treatment in renal transplant recipients: a systematic review","volume":"121","author":"Marra","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0365","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0090-4295(98)00211-8","article-title":"Prostate cancer in the post-transplant population","volume":"52","author":"Konety","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0370","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brachy.2013.11.003","article-title":"Locally advanced cervical cancer in renal transplant patients: a dilemma between control and toxicity","volume":"13","author":"Maroun","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0375","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.athoracsur.2014.04.014","article-title":"Primary lung cancer in lung transplant recipients","volume":"98","author":"Olland","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0380","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/hed.20898","article-title":"Sirolimus as a potential radiosensitizer in squamous cell cancer of the head and neck","volume":"31","author":"Shinohara","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0385","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1158\/1535-7163.MCT-05-0400","article-title":"Targeting the Akt\/mammalian target of rapamycin pathway for radiosensitization of breast cancer","volume":"5","author":"Albert","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0390","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1038\/sj.onc.1208715","article-title":"Enhanced radiation damage of tumor vasculature by mTOR inhibitors","volume":"24","author":"Shinohara","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0395","first-page":"5083","article-title":"Pelvic radiotherapy after renal transplantation","volume":"32","author":"Dahlke","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0400","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/jjco\/hyr133","article-title":"Adjuvant Radiotherapy for a Prostate Cancer After Renal Transplantation and Review of the Literature","volume":"41","author":"Detti","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0405","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/01.TP.0000137933.97259.E7","article-title":"Three-Dimensional Conformal Radiotherapy for Localized Prostate Cancer in Kidney Transplant Recipients","volume":"78","author":"Mouzin","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0410","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.transproceed.2016.01.032","article-title":"Efficacy and feasibility of intensity-modulated radiation therapy for prostate cancer in renal transplant recipients","volume":"48","author":"Iizuka","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0415","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.323.7314.665","article-title":"Premature osteonecrosis and sirolimus treatment in renal transplantation","volume":"323","author":"Bhandari","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0420","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1503\/cjs.032510","article-title":"Total hip arthroplasty in steroid-induced osteonecrosis: early functional and radiological outcomes","volume":"56","author":"Rahman","year":"2013","journal-title":"Can J Surg"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0425","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.canrad.2016.07.032","article-title":"D\u00e9lin\u00e9ation des organes \u00e0 risque et contraintes dosim\u00e9triques","volume":"20","author":"No\u00ebl","year":"2016","journal-title":"Cancer\/Radiother"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0430","first-page":"R81","article-title":"French ccAFU guidelines - Update 2018\u20132020: Prostate cancer","volume":"28 Suppl. 1","author":"Rozet","year":"2018","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0435","first-page":"46","article-title":"Osteomyelitis of the maxilla following radiotherapy for facial lupus","volume":"16","author":"Glasenapp","year":"1968","journal-title":"HNO"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0440","first-page":"1601","article-title":"Exaggerated fi brosis in patients with systemic sclerosis (scleroderma) following radiation therapy","volume":"20","author":"Abu-Shakra","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0445","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","article-title":"Understanding the epidemiology and progression of systemic lupus erythematosus","volume":"39","author":"Pons-Estel","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0450","first-page":"12","article-title":"Bioth\u00e9rapies des maladies auto-immunes\u00a0: quelles perspectives\u00a0?","volume":"15","author":"Arnaud","year":"2009","journal-title":"Med Therap"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0455","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jgyn.2014.12.011","article-title":"Pharmacologie du m\u00e9thotrexate","volume":"44","author":"Lagarce","year":"2015","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0460","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0162-3109(00)00189-2","article-title":"Mechanisms of action of methotrexate","volume":"47","author":"Genestier","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0465","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/anr.1780320903","article-title":"Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate","volume":"32","author":"Hirata","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0470","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3340\/jkns.2011.50.4.304","article-title":"Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia","volume":"50","author":"Kim","year":"2011","journal-title":"J Korean Neurosurg Soc"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0475","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/2278-330X.142990","article-title":"Methotrexate, an attractive agent for palliation in head and neck cancers","volume":"3","author":"Sharma","year":"2014","journal-title":"South Asian J Cancer"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0480","first-page":"872","article-title":"Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial","volume":"10","author":"Tobias","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0485","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2008.17.0530","article-title":"Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]","volume":"27","author":"Stewart","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0490","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.radonc.2011.06.025","article-title":"Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent","volume":"100","author":"Tortochaux","year":"2011","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0495","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0959-8049(03)00178-3","article-title":"Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients: a prospective, comparative, non-randomised study","volume":"39","author":"Fiets","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0500","series-title":"Acute Long-Term Side-Eff. Radiother. Recent results in cancer research","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-642-84892-6_6","article-title":"Early and late normal tissue injury after postmastectomy radiotherapy","author":"Bentzen","year":"1993"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0505","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/cncr.10744","article-title":"Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma","volume":"95","author":"Isaac","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0510","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/ijc.30214","volume":"139","author":"Pan","year":"2016","journal-title":"Int J Cancer"},{"year":"2016","series-title":"CRI-net\u00a0: fiches pratiques & eSessions SCRIPT\u00a0: Fiches pratiques du CRI\u00a0: prise en charge pratique des patients sous m\u00e9thotrexate","key":"10.1016\/j.bulcan.2019.09.010_bib0515"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0520","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1634\/theoncologist.7-2-136","article-title":"The effect of nonmalignant systemic disease on tolerance to radiation therapy","volume":"7","author":"Chon","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0525","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clon.2010.08.030","article-title":"Collagen Vascular Diseases and Enhanced Radiotherapy-induced Normal Tissue Effects \u2014 a Case Report and a Review of Published Studies","volume":"23","author":"Lee","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0530","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.clon.2012.04.001","article-title":"Radiation fibrosis \u2013 current clinical and therapeutic perspectives","volume":"24","author":"Westbury","year":"2012","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0535","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semradonc.2006.11.008","article-title":"Molecular mechanisms of late normal tissue injury","volume":"17","author":"Brush","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0540","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/S1470-2045(15)00417-9","article-title":"Radiotherapy in patients with connective tissue diseases","volume":"17","author":"Giaj-Levra","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0545","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2307\/3579442","article-title":"Delayed repair of DNA damage by ionizing radiation in cells from patients with juvenile systemic lupus erythematosus and rheumatoid arthritis","volume":"147","author":"McCurdy","year":"1997","journal-title":"Radiat Res"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0550","first-page":"239","article-title":"[Radiosensitivity of lymphocyte subpopulations in subjects with systemic lupus erythematosus. An in vitro preliminary study]","volume":"82","author":"Cossu","year":"1991","journal-title":"Minerva Med"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0555","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0961203309103150","article-title":"In-vitro radiosensitivity in patients with systemic lupus erythematosus","volume":"18","author":"Carrillo-Alascio","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0560","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10549-017-4438-7","article-title":"Impact of rheumatoid arthritis on radiation-related toxicity and cosmesis in breast cancer patients: a contemporary matched-pair analysis","volume":"166","author":"Dong","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0565","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cncr.23591","article-title":"Toxicity of radiotherapy in patients with collagen vascular disease","volume":"113","author":"Lin","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0570","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.1997.15.7.2728","article-title":"Irradiation in the setting of collagen vascular disease: acute and late complications","volume":"15","author":"Morris","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0575","doi-asserted-by":"crossref","first-page":"E463","DOI":"10.1016\/j.ijrobp.2015.07.1730","article-title":"Radiation toxicity in patients with collagen vascular disease: a meta-analysis of matched pair cohort series","volume":"93","author":"Shaikh","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0580","first-page":"480","article-title":"Breast-conserving therapy in the setting of collagen vascular disease","volume":"7","author":"Chen","year":"2001","journal-title":"Cancer J Sudbury Mass"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0585","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00130404-200311000-00005","article-title":"Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy","volume":"9","author":"Phan","year":"2003","journal-title":"Cancer J Sudbury Mass"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0590","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1002\/1097-0142(19930601)71:11<3744::AID-CNCR2820711144>3.0.CO;2-C","article-title":"Acute and late reactions to radiation therapy in patients with collagen vascular diseases","volume":"71","author":"Ross","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0595","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/1097-0142(19910801)68:3<502::AID-CNCR2820680310>3.0.CO;2-V","article-title":"Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease","volume":"68","author":"Robertson","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0600","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1001\/jama.1991.03460240088033","article-title":"Exaggerated radiation-induced fibrosis in patients with systemic sclerosis","volume":"265","author":"Varga","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0605","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0959-8049(95)00646-X","article-title":"Major interactions between radiation therapy and systemic sclerosis: is there an optimal treatment?","volume":"32A","author":"Delanian","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0610","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0360-3016(99)00103-0","article-title":"Collagen vascular diseases and radiation therapy: a critical review","volume":"44","author":"De Naeyer","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0615","doi-asserted-by":"crossref","first-page":"A87","DOI":"10.1016\/j.revmed.2018.03.323","article-title":"Traitement par radioth\u00e9rapie des cancers chez les patients atteints de scl\u00e9rodermie syst\u00e9mique","volume":"39","author":"Partouche","year":"2018","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0620","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijrobp.2006.09.003","article-title":"Radiotherapy for malignancy in patients with scleroderma: The Mayo Clinic experience","volume":"67","author":"Gold","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0625","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2007.11.031","article-title":"Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity","volume":"87","author":"Gold","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0630","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00000421-199802000-00012","article-title":"Radiotherapy for malignancies associated with lupus: case reports of acute and late reactions","volume":"21","author":"Rakfal","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0936-6555(03)00200-0","article-title":"Anal canal cancer and chemoradiation treatment in two patients with systemic lupus erythematosus treated by chronic therapeutic immunosuppression","volume":"16","author":"Khoo","year":"2004","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0640","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.20912","article-title":"Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer","volume":"53","author":"Benk","year":"2005","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0645","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijrobp.2007.10.014","article-title":"Systemic lupus erythematosus, radiotherapy, and the risk of acute and chronic toxicity: the Mayo Clinic Experience","volume":"71","author":"Pinn","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0650","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000354721","article-title":"Subacute Cutaneous Lupus Erythematosus Triggered by Radiotherapy","volume":"5","author":"Kolm","year":"2013","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0655","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bulcan.2018.02.005","article-title":"Radioth\u00e9rapie et maladies inflammatoires chroniques de l\u2019intestin\u00a0: revue de la litt\u00e9rature","volume":"105","author":"Jmour","year":"2018","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2019.09.010_bib0330","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ijrobp.2007.07.2357","article-title":"Radiotherapy in setting of collagen vascular disease","volume":"69","author":"Wo","year":"2007","journal-title":"Int J Radiat Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119304023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455119304023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:32:30Z","timestamp":1757791950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455119304023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0007455119304023"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.09.010","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radioth\u00e9rapie et immunosuppression\u00a0: synth\u00e8se de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2019.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}